27 related articles for article (PubMed ID: 3264171)
21. Compliance with oral chemotherapy in childhood lymphoblastic leukaemia.
Davies HA; Lilleyman JS
Cancer Treat Rev; 1995 Mar; 21(2):93-103. PubMed ID: 7758006
[No Abstract] [Full Text] [Related]
22. Pharmacokinetics and metabolism of methotrexate: an example for the use of clinical pharmacology in pediatric oncology.
Borsi JD; Sagen E; Romslo I; Moe PJ
Pediatr Hematol Oncol; 1990; 7(1):13-33. PubMed ID: 2204406
[No Abstract] [Full Text] [Related]
23. [Pharmacokinetics of methotrexate in children with acute lymphoblastic leukemia].
Lares-Asseff I; Paredes R; Taboada C; Cravioto J; Velázquez M; Roldán RM; Faisal AG
Bol Med Hosp Infant Mex; 1988 Oct; 45(10):671-80. PubMed ID: 3264171
[No Abstract] [Full Text] [Related]
24. Maintenance chemotherapy of acute lymphoblastic leukemia in children.
Schmiegelow K
Dan Med Bull; 1998 Nov; 45(5):510-32. PubMed ID: 9850812
[No Abstract] [Full Text] [Related]
25. [Results and suggestion from comparing between world excellent protocols of childhood acute lymphoblastic leukemia].
Fu RY; Liao QK; Jia CS
Zhonghua Er Ke Za Zhi; 2003 Jul; 41(7):515-9. PubMed ID: 14746678
[No Abstract] [Full Text] [Related]
26. Individualized dosages of chemotherapy as a strategy to improve response for acute lymphocytic leukemia.
Evans WE; Rodman J; Relling MV; Crom WR; Rivera GK; Crist WM; Pui CH
Semin Hematol; 1991 Jul; 28(3 Suppl 4):15-21. PubMed ID: 1780747
[No Abstract] [Full Text] [Related]
27. Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations.
Al-Mahayri ZN; Patrinos GP; Ali BR
Pharmacogenomics; 2017 May; 18(7):687-699. PubMed ID: 28468529
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
